Walleye Trading
SUPN icon

Walleye Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Walleye Trading’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,500
Closed -$163K – 5188
2023
Q1 		$163K Buy
+4,500
New +$173K ﹤0.01% 3644
2021
Q3 		– Sell
-200
Closed -$6K – 5694
2021
Q2 		$6K Buy
+200
New +$6.13K ﹤0.01% 4998

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Trading's SUPN Position: Q2 2023 in Review

Walleye Trading sold out of Supernus Pharmaceuticals (SUPN) in Q2 2023, closing a stake of 79 shares — an estimated $2.86K sold.

Walleye Trading first reported a position in SUPN in Q3 2015 and held it in 8 quarters. The position peaked at $636K in Q3 2015. 249 funds tracked by Wall St. Rank hold SUPN as of Q2 2023.

  • Walleye Trading reported no remaining Supernus Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 79 Supernus Pharmaceuticals shares in Q2 2023, an estimated $2.86K.
  • Walleye Trading first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 8 quarters.
  • Walleye Trading's Supernus Pharmaceuticals position peaked at $636K in Q3 2015.
  • 249 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.